BUZZ-Pacira BioSciences participated in a Viatris acquisition deal worth 1.65 billions dollars
路透社2026/10/08 16:11Latest Update October 8 – Pacira BioSciences (PCRX.O) shares surged by 44%, hitting a more than three-year high at $36.30. If the rally holds, PCRX is poised for its largest single-day gain on record. Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences in a $1.65 billion cash deal, offering $36.50 per share. The offer represents a premium of approximately 44.8% over Pacira’s recent closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris' product portfolio. Viatris shares fell 2.6% to $17.04. JPMorgan stated: “We believe this acquisition will not significantly alter VTRS' overall financial profile in the short or long term, and expect Exparel’s sales to gradually decline post-2030 due to generic market entry.” Both parties expect to complete the transaction by the end of 2026. Including intraday fluctuations, PCRX shares have risen 40.2% year-to-date, while VTRS has gained 36.8%. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translated texts and provides them for readers’ convenience only. Reuters assumes no liability for any damage or losses resulting from the use of automated translation.)
Latest Developments
October 8 - ** Pacira BioSciences (PCRX.O) shares surged 44%, hitting a three-year high of 36.30 USD
** If the rally persists, PCRX is set to record its largest single-day gain in history
**Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences for $1.65 billion in cash ((link)), at a price of $36.50 per share
** The offer represents a premium of about 44.8% over Pacira's recent closing price of $25.20
** The deal will add Pacira’s non-opioid pain drugs Exparel and Zilretta to Viatris’ product portfolio
** Viatris shares fell 2.6%, closing at $17.04
** JPMorgan stated: "We believe this acquisition will not markedly alter VTRS’s overall financial profile in the short or long term, and we expect sales of Exparel to gradually decline from 2030 onwards due to the entry of generics."
** Both parties expect the deal to be completed by the end of 2026
**Including intraday volatility, PCRX has risen 40.2% year-to-date, while VTRS has climbed 36.8%
(To facilitate non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them for readers’ convenience only. Reuters accepts no responsibility for any damage or loss resulting from the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media holds 4,260 bitcoin
Update: US Equity Indexes Drop as Sharp Sell-Off in Semiconductor Heavyweights Sinks Technology While Crude Oil Surges
03:39 PM EDT, 10/08/2026 (MT Newswires) -- (Updates with index/price moves and geopolitical news from the first paragraph.) US equity indexes fell as a sell-off in semiconductors pushed technology to the bottom of sector charts, while crude oil surged ahead of Thursday's close. The Nasdaq Composite dropped 1.4% to 27,153.2, the S&P 500 declined 0.6% to 7,750.1, and the Dow Jones Industrial Average slid 0.1% to 51,114.6. Energy and consumer staples led gainers. Among stocks with market capitalization exceeding $200 billion, all of the top 10 names were technology companies, and within those, eight were from semiconductor-related industries, according to data compiled by Finviz. The three worst performers in this mega-cap category were Arm (ARM), Intel (INTC), and Oracle (ORCL), down by at least 6.1% each. Meanwhile, tankers are facing a higher risk of attacks and intimidation as they try to get critical shipments through the Strait of Hormuz after Iran issued new warnings that it would block routes that it has not authorized, sources told Reuters. This comes as tropical storm Isaias continues to strengthen ahead of landfall on the northern Gulf Coast by this weekend, CNN reported. The storm rapidly intensified into the Atlantic season's first hurricane on Wednesday night, the news report added. Chevron (CVX) has begun shut-in procedures for production at four Gulf of America facilities and is evacuating workers as Isaias approaches, the company said. Front-month US West Texas Intermediate crude oil contract advanced 3.8% to $91.67 per barrel, and global benchmark Brent jumped 4.3% to $104.51 per barrel even after President Donald Trump reportedly said Thursday that the US will not attack Iran before the mid-term elections in early November while pointing out "productive discussions" with Tehran. The US borrowing costs at Treasury auctions continued to rise on Thursday. An auction of $22 billion of 30-year bonds hit a high yield of 5.618%, up from 5.308% in the previous auction. The bid-to-cover ratio, which measur
Forex Today: US flash Consumer Sentiment and Canadian jobs in the limelight
Malaysian Ringgit: Fiscal anchor case – MUFG
